Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Semaphorin 4 in multiple sclerosis].
Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis.
Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.
Current and Emerging Therapies for Multiple Sclerosis.
Visual outcomes in pediatric optic neuritis.
Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis.
Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Transcriptomic profile of host response in mouse brain after exposure to plant toxin abrin.
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Sodium accumulation is associated with disability and progression in multiple sclerosis: a 23na MRI study.
Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Voiding Dysfunction in Multiple Sclerosis.
Harnessing the integrated stress response for the treatment of multiple sclerosis.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation.
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings.
Endothelin regulates function of IL-17-producing T cell subset.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice.
Pages
« first
‹ previous
…
663
664
665
666
667
668
669
670
671
…
next ›
last »